Skye Bioscience, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
Skye Bioscience, Inc. (SKYE) reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 70.00% for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-12.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2017-05-12
- Skye Bioscience, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 70.00%, a 0.00% change year-over-year.
- Skye Bioscience, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 70.00%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month |
|---|---|
| 2017-03-31 | 70.00% 10-Q · filed 2017-05-12 |
| 2016-03-31 | 70.00% 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |